Navigation Links
Using the VersaFluor Fluorometer to Quantitate GUS Expression in Plant Tissues Bombarded With the Biolistic PDS-1000/He System

Nicholas N. Lyssenko and Mark L. Tucker, Soybean and Alfalfa Research Lab, USDA, ARS, Bldg. 006, BARC-West, Beltsville, MD, USA 20705

In 1987 Jefferson et al. described the use of β-glucuronidase (GUS) as a marker to study gene expression in plants. Expression of GUS activity in plant tissue can be quantified by fluorometry or assayed qualitatively by histochemistry. The GUS enzyme cleaves the commercially available substrate 4-methylumbelliferyl-β-D-glucuronic acid (MUG) to produce fluorescent methylumbelliferone (MU). The VersaFluor fluorometer, when equipped with the simple-to-install 360 excitation and 460 emission filters, has the necessary sensitivity to accurately measure MU in plant tissues. Quantification of GUS activity using the VersaFluor fluorometer is relatively inexpensive and reliable. We have used the instrument to quantify transient expression of a CaMV 35S-GUS construct in bean abscission zones. Abscission is the process by which plants shed organs. The bean abscission cellulase (BAC) accumulates tissue specifically in induced abscission zones. GUS expression is used as an internal control in experiments designed to identify regulatory regions in the BAC gene promoter. An example of the approach used and results obtained is described below. In addition to quantification of GUS activity, we use the VersaFluor fluorometer equipped with the same set of filters to quantify the DNA preparations. The fluorescent dye for DNA quantification is Hoechst 33258 from Bio-Rad.

Materials and Methods
The promoter to be tested for hormonal or tissue-specific expression is fused to the luciferase gene taken from the pDO432 plasmid (Ow et al., 1986; see Koehler et al., 1996, for details of promoter construction). The GUS gene is fused to an enhanced 35S promoter (Kay et al., 1987). An accurate measure of the concentration of the gene constructs is determined with the VersaFluor fluorometer using the Hoechst 33258 dye from Bio-Rad. The two constructs are then co-precipitated at constant and equal-molar concentrations onto gold particles (Figure 1A). Plant material is bombarded with the gold particles using the Biolistic PDS-1000/He particle gun (Bio-Rad) as depicted in Figure 1B.

Following particle bombardment and a 48-hour incubation period in ethylene (a plant hormone that induces abscission), approximately 1 mm of tissue is harvested from the upper surface of the bombarded explants (abscission zones, petioles and stems), and frozen separately in liquid nitrogen (Figure 1B). The protein extraction procedure is modified from the original protocol described by Jefferson et al. (1987) to allow the assay of cellulase, luciferase, and GUS activity from the same tissue extract. Approximately 150 mg of plant tissue is ground in liquid nitrogen, thawed in 450 l of extraction buffer (0.1 M sodium phosphate, pH 7.8, 1% Triton X-100, 2 mM EDTA, 1 mM DTT and 0.1% BSA), vortexed and then centrifuged at 10,000 rpm in a microcentrifuge for 4 minutes.

The supernatant is then transferred to new tubes in 75 l aliquots for measurement of cellulase and luciferase activity as described elsewhere (Koehler et al., 1996). For GUS assay, 75 l of the supernatant is combined with 25 l of a GUS adjustment buffer (0.4 M citrate buffer pH 5.5, 34 mM EDTA and 17 mM DTT) and the combined mixtures incubated at 55 C for 30 minutes. The GUS marker enzyme, originally from E. coli, is resistant to heat inactivation at 55 C; however, heating significantly reduces endogenous GUS-like activity in plant extracts. Following incubation, the mixture is combined with 20 l of methanol, which further reduces background GUS-like activity (Kosugi et al., 1990), and 12.5 l of 10 mM MUG. Immediately after addition of MUG, 10 l of the mixture is removed and combined with 2 ml of 0.2 M sodium carbonate to stop GUS conversion of MUG to MU. These tubes are labeled T0. The remaining mixture is incubated at 37 C overnight and the T0 tubes stored in the dark at room temperature. Following incubation at 37 C, 10 l of the mixture is combined with 2 ml of 0.2 M sodium carbonate and the tube labeled T12.

MU standards are prepared at 50, 100 and 500 nM in 0.2 M sodium carbonate. The VersaFluor fluorometer is warmed for 15 minutes before conducting the assay. The instrument has low, medium and high gains. The range of MU standards described above is best measured at a medium gain.

The instrument is zeroed with a blank consisting of 0.2 M sodium carbonate. First, the highest standard, 500 mM, is measured and set to equal 5,000 relative units with the range option of the fluorometer. Next, the two remaining standards are measured to ascertain a linear response. Finally, the fluorescence of extracts in the T0 and T12 tubes is measured and recorded.

Results and Discussion
Fusion of the enhanced CaMV 35S promoter (Kay et al., 1987) to the GUS reporter gene creates a gene construct (D35S) that expresses GUS constitutively in transformed plant tissues. Inclusion of this construct is used as an internal control to reduce variability in all our particle bombardment experiments (Figure 1A). The expression results (Figure 2B) are reported as the ratio of luciferase to GUS activity normalized to 100% for BKm3 expression in abscission zones. Expression of luciferase from the test promoter, the BKm3 construct (Figure 1A), relative to GUS expression from D35S (i.e., luciferase to GUS ratio) in stems and petioles is approximately 10% of the expression in abscission zones (Figure 2B). This pattern of expression is very similar to that for native cellulase activity measured in the same extracts collected from particle bombarded stems, petioles and leaf abscission zones (LAZ) (Figure 2A).

The VersaFluor fluorometer is inexpensive and easy to use. It has the necessary sensitivity to reproducibly measure transient GUS activity in particle gun bombarded plant tissues. In addition, using the Hoechst 33258 dye to quantitate DNA by the VersaFluor fluorometer is reliable, simple, and accurate.

1. Jefferson, R. A., Kavanagh, T. A. and Bevan, M. W., EMBO 6, 3901-3907 (1987).

2. Kay, R., Chan, A., Daly, M. and McPherson, J., Science, 236, 1299-1302 (1987).

3. Koehler, S. M., Matters, G. L., Nath, P., Kemmerer, E. C. and Tucker, M. L., Plant Molec. Biol., 31, 595-606 (1996).

4. Ow, D. W., Wood, K. V., DeLuca, M., DeWet, J. R., Helinski, D. R., and Howell, S. H., Science, 234, 856-859 (1986).

Triton is a trademark of Rohm and Haas. Biolistic is a trademark of E.I. Du Pont de Nemours and Co. Biolistic technology is exclusively licensed to Bio-Rad Laboratories.

back to top


Page: All 1 2 3 4

Related biology technology :

1. Low Abundance cDNA Cloned Using Stratagenes Human Universal cDNA Library
2. Oil-Free PCR Using the Hot Top Assembly
3. Functional Cloning Using ViraPort Retroviral cDNA Expression Libraries
4. Signal Transduction Reporting Systems Using Cis-Acting Enhancer Elements
5. Using XL1-Red Mutator Strain to Generate Esterase Variants
6. Detect Released Oligosaccharides Using the Eagle Eye II Still Video Imaging System
7. Comparison of Growth Techniques and Media for the Purpose of Plasmid Isolation from E. coli Using the Eppendorf Perfectprep Plasmid Mini Kit
8. Genomic DNA Extraction from Buccal Swabs Using the Perfect gDNA Blood Mini Kit
9. Genomic DNA Extraction from Buffy Coat Using the Perfect gDNA Blood Mini Kit
10. Isolation of Genomic DNA from Saliva Using the Perfect gDNA Blood Mini Kit
11. Protocol for RNA Isolation Using TRIzol Reagent with Phase Lock Gel-Heavy
Post Your Comments:
(Date:10/7/2015)... , Oct. 7, 2015  ContraVir Pharmaceuticals, Inc. (Nasdaq: ... company focused on the development and commercialization of targeted ... public offering of 5,000,000 shares of its common stock ... the Company,s common stock at a fixed combined price ... stock and warrants will be issued separately.  The warrants ...
(Date:10/7/2015)... , Oct. 7, 2015  October is National Liver Awareness ... committed to donating a portion of its October profits ... hepatology practices. ... a variety of ways; whether it is by providing ... collaborating with researchers in different disease and investigation areas, ...
(Date:10/7/2015)... Oct. 7, 2015   Intrexon Corporation (NYSE: ... announced it will hold an Investor Day in ... of Thursday, November 12, 2015. Intrexon,s Chairman and Chief ... members of the Company,s management team as well as ... on strategic initiatives, product pipeline, and program updates within ...
(Date:10/7/2015)... Texas (PRWEB) , ... October 07, 2015 , ... ... Assist Device (LVAD) has appointed S. Russel Craig of Spectral Platforms, and Michael ... has both substantial line management and consulting experience. Currently he is Executive Vice ...
Breaking Biology Technology:ContraVir Pharmaceuticals, Inc. Pricing Underwritten Public Offering Of Common Stock 2ContraVir Pharmaceuticals, Inc. Pricing Underwritten Public Offering Of Common Stock 3ContraVir Pharmaceuticals, Inc. Pricing Underwritten Public Offering Of Common Stock 4ContraVir Pharmaceuticals, Inc. Pricing Underwritten Public Offering Of Common Stock 5ContraVir Pharmaceuticals, Inc. Pricing Underwritten Public Offering Of Common Stock 6ContraVir Pharmaceuticals, Inc. Pricing Underwritten Public Offering Of Common Stock 7ContraVir Pharmaceuticals, Inc. Pricing Underwritten Public Offering Of Common Stock 8TRL Helps Increase Liver Awareness by Supporting Liver Research in October 2TRL Helps Increase Liver Awareness by Supporting Liver Research in October 3Intrexon to Host Investor Day 2Intrexon to Host Investor Day 3Intrexon to Host Investor Day 4Intrexon to Host Investor Day 5
... May 5 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:,ONC, NASDAQ: ... Meeting,of the Shareholders will be held on Wednesday, May ... of New York City, 50 Vanderbilt Ave, New York., ... Brad Thompson,President and CEO of Oncolytics, will discuss recent ...
... DIEGO, May 5 Biocept, an emerging leader in,biotechnology, ... of noninvasive,prenatal diagnostic tests that can be performed with ... of the American College of,Obstetricians and Gynecologists, May 3-7 ... Rh(D) status of a fetus in an Rh(D),negative pregnancy, ...
... On Thursday, May 8, 2008, at,8:30 a.m. ... Therapeutics, Inc.,s (CTI) (Nasdaq: CTIC ; MTA) ... discuss the company,s 2008 first,quarter achievements and financial ... May 8 8:30 a.m. Eastern/2:30 p.m. Central ...
Cached Biology Technology:Oncolytics Biotech Inc. Announces Details of 2008 Annual Shareholder Meeting 2Biocept Launches Noninvasive Prenatal Rh(D) Diagnostic at Annual ACOG Scientific Meeting 2
(Date:9/1/2015)... , Sept. 1, 2015  Automation and ... during airport passenger screening. This is the first ... screening process will become unintrusive. An assortment of ... on voluntary background investigations will transform the passenger ... & Sullivan, Global Airport Passenger Screening Market ...
(Date:8/31/2015)... Research and Markets ( ) has ... Sensors Market - Growth, Trends & Forecasts (2014-2020)" ... Arabia Biomedical Sensors market is estimated at $0.23 billion ... period 2014-2020 The near future will bring ... of each individual. These sensors can be set to ...
(Date:8/26/2015)... , August 26, 2015 ... Four, and Five Factor), Application (Travel & Immigration, Government, ... - Global Forecast to 2020", published by MarketsandMarkets, Multi-Factor ... by 2020, growing at a CAGR of 17.7% between ... and 82 F igures spread through 169 ...
Breaking Biology News(10 mins):The Future of Airport Security: Passenger Screening Transitioning Into an Invisible Process 2The Future of Airport Security: Passenger Screening Transitioning Into an Invisible Process 3The Future of Airport Security: Passenger Screening Transitioning Into an Invisible Process 4Saudi Arabia Biomedical Sensors Market Report 2015 - Growth, Trends & Forecasts (2014-2020) 2Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 2Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 3Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 4Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 5
... -- Resolvyx Pharmaceuticals, Inc., the leading resolvin therapeutics ... 2 clinical study evaluating RX-10045, a resolvin administered ... of patients with chronic dry eye syndrome. ... produced dose-dependent, statistically significant improvement on the primary ...
... spikes that stick out of nearly every cell in the ... cancer, new research has found. The discovery in mice shows ... suppress or promote this skin cancer, depending on the mutation ... that boost or block primary cilia activity could offer a ...
... , FORT WORTH, Texas, Aug. 4 ... are under 17. It is estimated that by 2010, human trafficking will ... Arthur Eisenberg, Ph.D., professor and chairman of the department of ... for Human Identification at the University of North ...
Cached Biology News:Resolvyx announces positive data -- Phase 2 trial of resolvin RX-10045 for dry eye syndrome 2Some skin cancer may be mediated by primary cilia activity 2Some skin cancer may be mediated by primary cilia activity 3DNA Helps Reunite Children With Their Families 2DNA Helps Reunite Children With Their Families 3
Anti-CaM kinase II recognizes the enzymes a subunit (6) and reacts with tissue from all mammalian species tested, as well as with chicken and frog tissues....
Anti-Src-Like Adaptor Protein-2 AVOID FREEZE/THAW CYCLES. Recognizes the ~25 and ~28 kDa forms SLAP-2....
... affinity media for spontaneous ligand immobilization can be ... enzyme, antigen, or receptor to create an affinity ... supports couple ligands via primary amines. Affi-Gel 10 ... from 6.5 to 11; Affi-Gel 15 gel couples ...
pH-dependent fluorescence; Maximum intensity observed in basic solutions....
Biology Products: